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Effective management of schizophrenia, acute mania, mixed episodes associated with bipolar disorders, 
and depression can be managed with aripiprazole moiety. In the present research work an attempt was 
made to minimize the dose related side effects thus improving the quality life of the patients. A novel 
biopolymer was isolated from the fruits of Trachyspermum ammi. Ten optimized nanosized aripiprazole 
loaded formulations were prepared in 1-5% concentration of biopolymer (FA1-FA5) and sodium CMC 
(FM1-FM5) by solvent casting technique. The formulated flexy films were evaluated for thickness, 
folding endurance, weight uniformity, surface pH, mucoadhesivity, In-vitro drug release studies, In-vivo 
pharmacodynamic study and stability studies. The isolated biopolymer showed inbuilt fimability and 
mucoadhesivity and consists of carbonyl, hydroxyl and thiocarbonyl functional groups. All formulations 
showed folding endurance from 153 to 170, mucoadhesion time in the range of 24-48hrs., and in-vitro 
drug release was performed using dynamic Franz Diffusion cell and analyzed using BIT-SOFTWARE. 
The experimental animals showed improved activity score on actophotometer. The formulated nanosized 
aripiprazole loaded bio-flexy films showed pharmacotherapeutic response. Conclusion can be drawn that 
optimized formulation showed effective Pharmacodynamic activity and can be used as for improving 
therapeutic efficacy of aripiprazole through this platform. 
Keywords: Aripiprazole/therapeutic efficacy. Nanosized. Mucoadhesive. Schizophrenia. Oro-soft palatal 
mucosal route.
INTRODUCTION 
Schizophrenia is self-disorder characterized by 
complementary distortions of the act of awareness i.e. 
hyperreflexivity and diminished self-affection (Sass, 
Parnas, 2003). Studies had suggested that the etiology 
of schizophrenia is yet unclear but it is believed that 
dopaminergic neural network has major role in its 
pathophsiology (Nekovarova et al., 2014). The symptoms 
of schizophrenia are positive and negative symptoms, 
and cognitive effects. The positive symptoms are 
conceptual disorganization, abnormal thought contents 
and hallucinations. Negative symptoms are reduction in 
normal functioning, flattened emotions, decrease of social 
behavior and anhedonia. Cognition is affected in several 
arena such as vigilance, psychomotor speed, impairment 
of memory functioning, social cognition (Green et al., 
2004). 
Ar ip iprazole  i s  used for  the  t rea tment  of 
schizophrenia, bipolar disorder, major depressive 
disorder, autism, and Tourette’s syndrome (USFDA 
approved label of ABILIFY). It is a second generation 
atypical antipsychotic which belongs to the benzisoxazole 
derivatives and has serotonin 5-HT1A-receptor partial 
agonist as well as 5- HT2A-receptor antagonist properties 
like a partial agonist at dopamine D2 receptors. It has 
a pKa value of 7.6 in 20% aqueous ethanol (Ardiana, 
Lestari, Indrayanto, 2013). Aripiprazole is a poorly 
soluble and poorly permeable compound with BCS class 
IV (Laszcz, Witkowska, 2016). It is weak alkaline drug 
which thus imparts pH-dependent solubility to it (Xu et 
al., 2012).
Aripiprazole is categorized under black box 
warning drugs as it increases the risk of death in geriatric 
patients having dementia-related psychosis when treated 
with antipsychotic drugs. This may be due to collapse, 
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infection or stroke. Also increases suicidal thinking and 
behavior in children, adolescents, and young adults taking 
antidepressants. Depression and other serious mental 
illnesses are themselves associated with an increased risk 
of suicide (Kalinichev et al., 2005; Otsuka Pharmaceutical, 
2002). 
The soft palate is the soft tissue present at the 
back of the roof of the mouth. The soft palatal mucosa 
is flexible, highly vascularized, having nonkeratinized 
stratified squamous epithelium about 100-200 µm thick, 
and it is supposed to be 4-4000 times more permeable 
than skin. The seromucous glands secrete saliva and 
facilitate adhesion. The blood supply to the palatal region 
comes from facial artery and is 0.89 mL/min/100 cm2. 
It is innervated through CN V (i.e. lesser palatine nerve) 
(Shankar, Madhav, 2015; Shakya, Madhav, Shakya, 
2011). 
The plant Trachyspermum ammi belonging to 
family Apiaceae, is commonly known as ajwain. The 
fruits are used as spice and available in the market whole 
year. The phytochemical analysis of plant showed 38.6% 
carbohydrate, 15.4% protein, 11.9% fiber and 7.1% 
minerals containing calcium, phosphorous, iron and 
nicotinic acid (Bairwa, Sodha, Rajawat, 2012). As on date 
literature reveals that no attempt was made for isolating 
biopolymer from Trachyspermum ammi, novel approach 
was made for isolating biopolymer from Trachyspermum 
ammi.
The current objective of our research work was to 
improve therapeutic efficacy of aripiprazole by delivering 
nanosized aripiprazole through soft palatal route. This can 
be achieved by formulating mucoadhesive bio-flexy film.
MATERIAL AND METHODS
Aripiprazole was received as gift sample from Sun 
Pharma (Mumbai), India. Trachyspermum ammi was 
procured from local market of Dehradun, Uttarakhand, 
India. Sodium CMC, D-glucose, 1,2,3-propanetriol and 
all other chemicals and solvents were of analytical reagent 
grade.
Isolation of biomaterial from the pulp of 
Trachyspermum ammi
250 grams fruits of Trachyspermum ammi were 
taken soaked in distilled water and subjected for hydro 
distillation using Clevenger’s apparatus for 48 h, 
filtered and air dried. Exhausted seeds were mixed with 
250 mL distilled water in a mixer to get smooth slurry 
and it was filtered through a muslin cloth. The filtrate 
was centrifuged at 3000 rpm to remove the extraneous 
matter. The supernatant liquid was treated with optimized 
quantity of propanone and kept in refrigerator for 24 h. 
The bio-material was separated by centrifugation at 
4000 rpm for 25 min. The bio-material was dried in 
desiccator for 48 h. The bio-material extraction was 
repeated 6 times & practical yield was reported (Madhav, 
Shankar, 2011). 
Physico-chemical characterization and spectral 
analysis of the isolated bio-material
The isolated bio-material was tested for various 
physico-chemical properties like colour, odour, solubility, 
color changing point, chemical tests for carbohydrates 
(molisch test, benedict’s), proteins (biuret test) and starch, 
and spectral studies like I.R Spectra was performed using 
Shimadzu IR Tracer-100.
In-vitro mucoadhesivity study of isolated 
bio-polymer
The isolated bio-polymers were screened for 
mucoadhesivity. The films were prepared in the ratios 
of 1-5% w/v biopolymer from T. ammi. The biopolymer 
was accurately weighed in different ratios and triturated 
with 10 µL of 1,2,3-propanetriol, and 80 mg of D-glucose 
as flexicizer. 10 mL of distilled water added into it and 
subjected for mechanical stirring for 30 min. The resulting 
solution was poured on petridish for natural drying of 
about 24 h. The dried bio-flexy films were tested for 
mucoadhesivity by Rotating Cylinder Method using Type 
II Dissolution apparatus goat intestinal mucosa. The fresh 
intestinal mucosa was attached over the cylindrical basket. 
The prepared flexy films were adhered to the membrane 
with gentle pressing. Then the cylinders were rotated at 
100 rpm in 900 mL of pH buffer 7.4 at 37±˚C. The films 
were observed at different time intervals and the time 
required for dislodgement and or disintegration was 
recorded (Madhav, Yadav, 2013).
Drug excipients interaction study
The drug interaction study was performed wet 
and dry method. The drug was physically mixed with 
excipients in dry method and in wet method the physical 
mixture was treated with 2 mL of distilled water in the 
ratios of 1:1, 1:3 and 3:1 and kept for a period of 3 days. 
Both the mixtures were dissolved in methanol and then 
analyzed by TLC and UV Spectrophotometric method at 
221nm (Kalaichelvi et al., 2009). 
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Formulation of nanosized Aripiprazole loaded 
flexy films
Aripiprazole was nanosized by using Novel method. 
The drug was dissolved in suitable solvent and 10 µL 
of 1,2,3-propanetriol was added as nanosizant into it. 
Propanetriol has the ability to enhance the wettability of 
aripiprazole and serves as good dispersing agent who aids 
in nanosizing of the particle hence it acts as nanosizant 
(Nalawde, Mukherjee, Kapoor, 2013).
10 mL of distilled water was added into it and 
sonicated for 5 cycles (each cycle of 3 mins). The solution 
was micro centrifuged at 10,000rpm for 15 min and 
residue was dried and collected. Optimized nanosized 
aripiprazole loaded flexy films using biopolymer and 
standard film former i.e. sodium CMC were prepared 
by using “Solvent casting method”. In this method 
biopolymer from T. ammi  and sodium CMC was 
accurately weighed in different ratios and triturated with 
10 µL of 1,2,3-propanetriol, and 80 mg of D-glucose 
as flexicizer. 10 mL of distilled water added into it and 
subjected for mechanical stirring for 30 min. 10 mg of 
drug was dissolved separately in ethanol. The nanosized 
drug solution was added to the polymeric solution under 
stirring 4,500 rpm. The polymeric solution was poured on 
petridish for natural drying of about 24 h. 
Nanosizing characterization by U.V spectroscopic 
method
It is a novel preliminary screening method for 
nanosizing range of particles by U.V spectroscopy and 
performed after each cycle of sonication. Transmittance is 
based on the concept of Tindal effect. When a light passes 
through a medium or solution which doesn’t contain 
solute between 200-400 nm size range 100% light gets 
transmitted. If a solvent contains any solute particles 
ranging 200-800nm then the particles may absorb a light 
and proportionally shows absorbance by reducing the %T 
0.05 by reducing / blocking 10% of absorbance and 90% 
of transmittance similarly 1% absorbance with 10 % T and 
90% blockage (Varley, 2005).
Evaluation of nanosized aripiprazole loaded flexy 
films
Appearance, weight uniformity and content uniformity 
study
All the flexy films were weighed three times then 
weight uniformity was calculated. All formulated flexy films 
were evaluated for its drug content uniformity. Selected 
film (1 cm2) was transferred into a 100 mL volumetric flask 
containing 7 mL of phosphate buffer of pH7.4 and 1 mL 
of methanol. The contents of flask were stirred for 4 h on 
magnetic stirrer. The drug content was then determined after 
appropriate dilutions by using an UV spectrophotometer 
(Shimadzu 1800) (Madhav, Yadav, 2013).
The drug content was calculated by using below 
equation:
Drug content = (Analyzed content/Theoretical content) 
x 100   (1)
TABLE I - Formulation table of optimized aripiprazole loaded bio-flexy films of Trachyspermum ammi
Formulation FA1 (1:1) FA2 (1:2) FA3 (1:3) FA4 (1:4) FA5 (1:5) 
Aripiprazole (mg) 10 10 10 10 10 
Trachyspermum ammi (mg) 1% 2% 3% 4% 5% 
D-glucose (mg) 80 80 80 80 80 
1,2,3-Propanetriol (µL) 10 10 10 10 10 
Distilled Water (mL) 10 10 10 10 10
TABLE II - Formulation table of optimized aripiprazole loaded flexy films of sodium CMC as Film former
Formulation FM1 (1:1) FM2 (1:2) FM3 (1:3) FM4 (1:4) FM5 (1:5) 
Aripiprazole (mg) 10 10 10 10 10 
Sodium CMC (mg) 1% 2% 3% 4% 5% 
D-glucose (mg) 80 80 80 80 80 
1,2,3-Propanetriol (µL) 10 10 10 10 10 
Distilled Water (mL) 10 10 10 10 10
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Folding endurance and surface pH
The selected films were subjected repeatedly folding 
a film (of area 2 cm2) at the same place until it broke and 
the number of folds recorded. The surface pH of flexy films 
was measured by using pH meter (Madhav, Yadav, 2013).
Mucoadhesion study
The mucoadhesive property of prepared films 
was evaluated by Rotating Cylinder method using goat 
soft palatal mucosa with phosphate buffer pH 7.4. After 
each 30 min and up to 36 h the film was observed for 
any dislodgement or disintegration from the soft palatal 
mucosal surface. The results were compared with the 
standard films of sodium CMC (Madhav, Yadav, 2013).
In-vitro drug release study
The In-vitro drug diffusion was carried out by using the 
Dynamic Franz diffusion cell method. Egg shell membrane 
was tied on the donor compartment and flexy film of 1 cm2 
area was kept on the above the membrane and the receiver 
compartment were filled with 7 mL of phosphate buffer 
pH7.4. 4 mL of sample was withdrawn at the intervals of 
0, 10, 20, 30, 60, 120, 180, 300, 360, 480 and1440 min and 
replaced with 4 mL of fresh medium. The amount of drug 
released was assessed by measuring the absorbance at 221 nm 
using UV spectrophotometer (Shimadzu 1800) (Madhav, 
Yadav, 2013; Kalaichelvi et al., 2009).
In-vivo pharmacodynamic study
The in-vivo pharmacodynamic study was performed 
by monitoring locomotor activity of Wistar albino rats 
using actophotometer. Rats were divided into two test 
groups (group I & II) and control (group III) each group 
containing two rats. Animals were maintained under light 
and dark cycle of 12 h in light and 12 h in dark under 25 °C 
and 70% RH. Animals were placed in actophotometer 
individually and basal activity score was recorded over 
the period of 5 min. Then the flexy film containing 1 mg of 
aripiprazole was applied on the soft palatal mucosa of test 
group I, group II received oral solution of aripiprazole and 
activity score was recorded after 30 min and 1 hr (Bhosale 
et al., 2011).
Stability study
Optimized best flexy film was subjected to stability 
study as per ICH guidelines. The film were kept in an 
incubator (stability study chamber) maintained at 37±5 °C 
and 75±5%R.H. for 6 months. The change in appearance, 
physical characteristics and release behavior of the stored 
films were investigated from 0-6 months (Ezhumalai et 
al., 2011).
RESULTS AND DISCUSSION
Isolation, physico-chemical characterization and 
Spectral analysis of isolated bio-material from 
Trachyspermum ammi
The % yield of Trachyspermum ammi was found to 
be 5.1±1.05%. The isolated biomaterial is carbohydrate 
and proteinaceous in nature. The physico-chemical 
characterization is shown in table IIIa and IIIb). The 
bio-material was purified by hot dialysis method and 
it was devoid of chlorides and sulfates. The functional 
groups of bio-material were elucidated by I.R. spectral 
studies.
The I.R. spectral interpretation by IR Pal V 2.0 
reported the presence of hydroxyl (3408 cm-1), alkanes, 
alkenes, phosphonic (2668 cm-1), phosphine (2430 cm-1), 
amides (1636 cm -1), carboxylic acid (1398 cm -1), 
thiocarbonyl (1117 cm -1) and alkyne (620 cm -1). 
(Figure 1). These functional groups are responsible for 
the mucoadhesive property of the biopolymer. 
In-vitro mucoadhesivity study of isolated 
bio-polymer
The isolated biopolymer showed maximum 
mucoadhesion time of 48 hrs at the concentration of 
5%. The results revealed that as the concentration of 
biopolymer was increased there was also an increase in 
mucoadhesion time which can be explored for designing 
mucoadhesive dosage form (Figure 2).
TABLE IIIA - Characterization of bio-materia 
S.No. Test Observation Inference
1. Molisch + Carbohydrate present
2. Benedict + Carbohydrate present
3. Biuret + Proteins present
TABLE IIIB - Characterization of bio-material
Colour Brown
Odour Characterstic
Taste Characterstic
Solubility Slightly soluble in water
Melting Point 255±10˚C
A smart approach for delivery of aripiprazole via oro-soft palatal mucosal route for improved therapeutic efficacy
Braz. J. Pharm. Sci. 2018;54(3):e17382 Page 5 / 9
Drug excipients interaction study
The studies revealed that there was no interaction 
between the drug and the excipients including the bio-
polymer. This was confirmed by the result of the thin layer 
chromatography in which no change was seen in the Rf 
value. Also there was no change in the ƛ max and absorbance 
also. Since excipients doesn’t have any reacting group hence 
selected for further processing. Value which was observed 
to be 221 nm prior to the test and after the test it was 221 
nm hence confirming that there was no interaction between 
the drug and excipients. It was concluded that none of the 
excipients had a deleterious effect on the drug and could be 
used for the formulation of the flexy-films. 
Nanosizing characterization by U.V spectroscopic 
method
% Transmittance was measured before and after 
each cycle of sonication. As the number of sonication 
cycles was increased there was an increase in the % 
transmittance indicating that the particles may be gone in 
nano range thus increasing the transmittance (Figure 3).
Evaluation of prepared nanosized aripiprazole 
loaded flexy films
Nanosized Aripiprazole loaded bio-flexy films 
(FA1-FA5 and FA1-FA5) were prepared by using 
biopolymer isolated from Trachyspermum ammi as 
mucoadhesive film former, sodium CMC as standard 
polymer, D-glucose as flexicizer and other co-processing 
agent like 1,2,3-propanetriol as plasticizer. 
All the prepared formulations were subjected for 
different evaluation parameters.
Appearance, weight uniformity and content uniformity 
study 
All flexy films were transparent in nature, smooth in 
appearance, and flexible in nature. The weight variation 
FIGURE 1 - I.R. Spectra of Trachyspermum ammi.
FIGURE 2 - In-vitro Mucoadhesion study of isolated bio-polymer.
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and % drug content of all the flexy film formulas was in the 
range of 23.73 to 34.48 mg and 96.4-98.9% respectively 
as shown in Table IV.
Folding endurance and surface pH
The results were shown in the Table IV. All the 
prepared formulations (FA1-FA5 and FM1-FM5) showed 
folding endurance in the range of 153 to 170 folds. Folding 
endurance study revealed that there was slight increase in 
the flexibility of the films as the polymeric concentration 
was increased in the formulations. FM5 showed maximum 
folding endurance of 170 times in comparison to other 
formulations, this may be due to the presence of optimum 
concentration of polymer and flexicizer. FA1 showed 
minimal folding endurance of 153 times. All the prepared 
formulations (FA1-FA5 and FM1-FM5) showed a surface 
pH in the range of 7.31 to 7.41 which is near to neutral 
in nature and devoid of irritation as formulations were 
prepared by using biopolymeric substance which is edible, 
biocompatible, economical and devoid of any mucosal 
irritant groups.
Mucoadhesion study
The mucoadhesion of the prepared films was 
assessed by in-vitro Rotating Cylinder method using 
goat soft palatal mucosa. All the formulations showed 
significant mucoadhesion time and as the concentration 
of polymer was increased there was proportional increase 
in the mucoadhesion time. (Figure 4) The In-vitro 
mucoadhesion study showed that formulation FA5 and 
FM5 had maximum mucoadhesion for a period of 48 h. 
This may be due to presence of mucoadhesive functional 
groups like carboxylic and thiocarbonyl and optimized 
proportion of polymer. FA1 showed least mucoadhesion 
time over a period of 22 h this may be due to the minimum 
concentration of biopolymer and/or overdhyration. 
FIGURE 3 - Nanosizing charaterization by UV spectroscopic method.
TABLE IV - The pH, weight, folding endurance and percent of drug content in Aripiprazole loaded flexy film formulations
Formulation 
Code pH
Weight Uniformity 
(mg)
Folding Endurance 
(folds) % Drug content
FA1 7.41± 0.05 21.89± 0.06 153± 0.5 97.1± 0.04
FA2 7.38± 0.07 24.54± 0.05 156± 0.6 98.9± 0.03
FA3 7.35± 0.08 25.73± 0.07 154± 0.4 98.3± 0.05
FA4 7.33± 0.06 24.71± 0.06 157± 0.2 97.4± 0.07
FA5 7.35± 0.05 23.98± 0.08 162± 0.3 96.8± 0.05
FM1 7.31± 0.04 22.73± 0.03 164± 0.7 98.4± 0.04
FM2 7.40± 0.06 23.56± 0.04 162± 0.2 98.5± 0.04
FM3 7.39± 0.05 24.78± 0.06 163± 0.3 96.4± 0.03
FM4 7.34± 0.06 23.01± 0.05 167± 0.4 96.8± 0.05
FM5 7.33± 0.07 24.48± 0.07 170± 0.5 97.2± 0.04
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Upon increasing the biopolymer and standard polymer 
concentration there was an appreciable increase in the 
mucoadhesion time. 
In-vitro drug release study
The In-vitro drug release kinetics was analyzed by 
BIT-SOFTWARE. The t50% and t 80% of formulations 
were calculated and reported. 
The comparative drug release profile of all the 
formulations showed that the drug released followed the 
descending order: FA2 > FM1 > FA4 > FM5 > FA5 > 
FM3 > FA1 > FA3 > FM4 > FM2 (Figure 5).
The In-vitro drug release study revealed that 
formulation t50% from 3.1-4.5 h, and released drug up to 
24 h. Biopolymer showed drug release retardation property 
and released drug for a longer period of time thus reducing 
the dosing frequency.
In-vivo Pharmacodynamic study
The photoactometer study showed the evidence 
of greater central nervous system stimulation by the 
nanosized drug loaded flexy film application in rats of 
group I in the form of increased activity score. While the 
rats in test group II does not showed comparable increase 
in activity score (Figure 6).
The results of in-vivo Pharmacodynamic study 
showed that there was increase in the locomotor activity 
of experimental animals (group I) after flexy film 
application, signifies the increased dopaminergic activity 
in brain. Comparing the results it suggested that the 
FIGURE 5 - In-vitro drug release study by franz diffusion cell apparatus.
FIGURE 4 - In-vitro Mucoadhesion Study by Rotating Cylinder Method.
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locomotor acitivity due to the drug was much more in the 
group receiving nanosized aripiprazole than the group 
administered with plain oral solution of drug at same 
dose level.
Stability study
The best formulation was stable over a period of 6 
months as there was no change in the physical appearance, 
drug content and in-vitro release. 
On comparison of the performance of all flexy 
films including texture, flexibility, surface pH, weight 
uniformity, content uniformity, folding endurance, 
mucoadhesivity, In-vitro drug release retardibility, in-
vivo Pharmacodynamic study the FA2 formulation with 
R2 value 0.9121 was selected as best optimized film. The 
above results indicated that administration of nanosized 
Aripiprazole via oro-soft palatal route increased its 
therapeutic performance
CONCLUSION
The isolated biopolymer from Trachyspermum 
ammi can serve as film former and it can be used for 
designing various drug loaded flexy films. Delivery 
of aripiprazole can be significantly enhanced by 
administering in the form of nanosized aripiprazole 
loaded bio-flexy film on soft palatal mucosa as it is 
enriched with nerve supply, so it showed significant 
Pharmacodynamic activity. Hence it was concluded 
that oro-soft palatal mucosa can serve as novelistic 
platform for effective delivery of Aripiprazole to produce 
significant Pharmacodynamic response. 
FIGURE 6 - Pharmacodynamic study by Photoactometer.
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